Alcoa Appoints Thomas Gorman as Non-Executive Chairman-March 2024-www.financetom.com

Alcoa Appoints Thomas Gorman as Non-Executive Chairman

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Alcoa Appoints Thomas Gorman as Non-Executive Chairman

May 26, 2025 4:54 AM

05:39 AM EDT, 05/09/2025 (MT Newswires) -- Alcoa ( AA ) said late Thursday it has named Thomas Gorman as non-executive chairman of the board.

Gorman, a board member since May 2021, succeeded Steven Williams, who stepped down after more than eight years of service.

Previous page： Whitestone REIT Receives Unsolicited, Non-Binding Acquisition Proposal Next page： Astera Labs Q3 Non-GAAP Earnings, Revenue Rise; Q4 Guidance Issued; Shares Rise After Hours

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Whitestone REIT Receives Unsolicited, Non-Binding Acquisition Proposal

Nov 4, 2025

HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Whitestone REIT ( WSR ) , a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced that it has received an unsolicited, non-binding proposal from MCB Real Estate to acquire all of the outstanding shares of the Company’s common stock for cash consideration of $15.20 per share. MCB...

Astera Labs Q3 Non-GAAP Earnings, Revenue Rise; Q4 Guidance Issued; Shares Rise After Hours

Nov 4, 2025

04:15 PM EST, 11/04/2025 (MT Newswires) -- Astera Labs ( ALAB ) reported Q3 non-GAAP net income late Tuesday of $0.49 per diluted share, up from 0.23 a year earlier. Analysts polled by FactSet expected $0.39. Revenue for the quarter ended Sept. 30 was $230.6 million, up from $113.1 million a year earlier. Analysts surveyed by FactSet expected $206.5 million....

Cadre Holdings Reports Third Quarter 2025 Financial Results

Nov 4, 2025

Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1% Organic Backlog Increased $20 Million from Q2 to Q3 Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026 Agrees to Acquire TYR Tactical, Leading Provider...

Amgen Q3 Adjusted Earnings, Revenue Increase; 2025 Guidance Raised

Nov 4, 2025

04:14 PM EST, 11/04/2025 (MT Newswires) -- Amgen ( AMGN ) reported Q3 non-GAAP net income late Tuesday of $5.64 per diluted share, up from $5.58 a year earlier Analysts polled by FactSet expected $5.02. Revenue for the quarter ended Sept. 30 was $9.56 billion, up from $8.50 billion a year earlier. Analysts expected $8.97 billion. For fiscal 2025, the...